EKSO
Ekso Bionics Holdings Inc
NASDAQ: EKSO · HEALTHCARE · MEDICAL INSTRUMENTS & SUPPLIES
$12.01
+4.98% today
Updated 2026-04-30
Market cap
$39.16M
P/E ratio
—
P/S ratio
3.06x
EPS (TTM)
$-4.91
Dividend yield
—
52W range
$3 – $14
Volume
0.1M
Ekso Bionics Holdings Inc (EKSO) Financial statements
SEC filings — annual and quarterly data.
Profit margin
-91.40%
Operating margin
-119.70%
ROE
-107.60%
ROA
-33.60%
Debt/equity
0.31x
Margin trends — annual
Gross margin Operating margin Profit margin
| Year | Revenue | Net income | Gross margin | Op. margin | Profit margin |
|---|---|---|---|---|---|
| 2012 | $2.71M | $-15.04M | 13.67% | -526.27% | -555.88% |
| 2013 | $3.30M | $-12292.00 | 17.78% | -0.37% | -0.37% |
| 2014 | $5.33M | $-33.77M | 29.27% | -315.26% | -633.92% |
| 2015 | $8.66M | $-19.59M | 13.61% | -248.94% | -226.19% |
| 2016 | $14.22M | $-23.47M | 20.72% | -193.98% | -165.04% |
| 2017 | $7.35M | $-29.12M | 28.14% | -429.92% | -396.06% |
| 2018 | $11.33M | $-26.99M | 38.03% | -238.53% | -238.19% |
| 2019 | $13.92M | $-12.13M | 48.60% | -119.56% | -87.17% |
| 2020 | $8.88M | $-15.82M | 57.08% | -144.76% | -178.17% |
| 2021 | $11.25M | $-9.76M | 60.01% | -122.96% | -86.82% |
| 2022 | $12.91M | $-15.08M | 48.13% | -120.48% | -116.79% |
| 2023 | $18.28M | $-15.20M | 49.67% | -82.67% | -83.14% |
| 2024 | $17.93M | $-11.33M | 53.06% | -58.35% | -63.21% |
| 2025 | $12.80M | $-11.70M | 53.48% | -104.12% | -91.37% |